Risk Factors in the Treatment of Rheumatoid Arthritis with Parenteral Gold
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 12 (sup51) , 112-115
- https://doi.org/10.3109/03009748309095362
Abstract
(1983). Risk Factors in the Treatment of Rheumatoid Arthritis with Parenteral Gold. Scandinavian Journal of Rheumatology: Vol. 12, No. sup51, pp. 112-115. doi: 10.3109/03009748309095362Keywords
This publication has 7 references indexed in Scilit:
- HLA DR antigens and gold toxicity.Annals of the Rheumatic Diseases, 1983
- Clinical responses during gold therapy for rheumatoid arthritis. changes in synovitis, radiologically detectable erosive lesions, serum proteins, and serologic abnormalitiesArthritis & Rheumatism, 1982
- Serum IgE concentrations in rheumatoid arthritis: lack of correlation with gold toxicity.BMJ, 1979
- Serological typing of HLA-D: Predictive value in mixed lymphocyte cultures (MLC)Immunogenetics, 1978
- Some Characteristics of RA Patients with and Without Side Effects Due to Gold TreatmentScandinavian Journal of Rheumatology, 1977
- Gold Therapy in Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 1961